OXIM-patent granted in Australia


Swedish Pharma can today announce that the Australian Patent Office (APO) has granted the patent related to a novel pro-drug referred to as OXIM.

Contact Us

Send us an email if you have any questions and we'll get back to you.

DSC_1808